Advertisement
Screener

Personalis, Inc. (PSNL) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

Personalis, Inc. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • Personalis, Inc. pe ratio for the quarter ending 2026-06-30 was -13.3, a change of -6.93 year-over-year.
  • Personalis, Inc. pe ratio for the quarter ending 2026-03-31 was -6.97, a change of -3.29 year-over-year.
  • Personalis, Inc. pe ratio for the quarter ending 2025-12-31 was -10.04, a change of -3.99 year-over-year.
  • Personalis, Inc. pe ratio for the quarter ending 2025-09-30 was -7.84, a change of -3.69 year-over-year.
  • Personalis, Inc. pe ratio for fiscal 2026 was -13.3.
  • Personalis, Inc. pe ratio for fiscal 2025 was -10.04, a change of -3.99 from fiscal 2024.
  • Personalis, Inc. pe ratio for fiscal 2024 was -6.06, a change of -5.08 from fiscal 2023.
  • Personalis, Inc. pe ratio for fiscal 2023 was -0.98, a change of -0.16 from fiscal 2022.
Available history
2019-06-30 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-13.3$1.43B-$107.18M
2026-03-31-6.97$666.36M-$95.55M
2025-12-31-10.04$816.22M-$81.27M
2025-09-30-7.84$579.51M-$73.88M
2025-06-30-6.37$581.99M-$91.32M
2025-03-31-3.69$310M-$84.07M
2024-12-31-6.06$492.29M-$81.28M
2024-09-30-4.16$380.03M-$91.44M
2024-06-30-0.76$62.07M-$81.45M
2024-03-31-0.83$76.58M-$92.61M
2023-12-31-0.98$106.01M-$108.3M
2023-09-30-0.53$59.31M-$112.78M
2023-06-30-0.83$91.19M-$110.17M
2023-03-31-1.13$129.1M-$113.77M
2022-12-31-0.82$92.48M-$113.32M
2022-09-30-1.33$136.49M-$102.45M
2022-06-30-1.69$158.33M-$93.62M
2022-03-31-4.57$370.6M-$81.03M
2021-12-31-9.82$640.79M-$65.23M
2021-09-30-14.74$860.15M-$58.37M
2021-06-30-22.26$1.12B-$50.24M
2021-03-31-24.2$1.08B-$44.55M
2020-12-31-34.68$1.43B-$41.28M
2020-09-30-24.31$840.58M-$34.58M
2020-06-30-12.95$413.38M-$31.92M
2020-03-31-8.92$254.45M-$28.54M
2019-12-31-13.58$340.55M-$25.08M
2019-09-30-20.78$457.02M-$21.99M
2019-06-30-45.06$844.95M-$18.75M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-13.3$1.43B-$107.18M
2025-12-31-10.04$816.22M-$81.27M
2024-12-31-6.06$492.29M-$81.28M
2023-12-31-0.98$106.01M-$108.3M
2022-12-31-0.82$92.48M-$113.32M
2021-12-31-9.82$640.79M-$65.23M
2020-12-31-34.68$1.43B-$41.28M
2019-12-31-13.58$340.55M-$25.08M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
CareDx, Inc. (CDNA)United States$3.174B13.21
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64